The abstract is read at the publisher; the summary is JClub's.
HypoAD links ageing and Alzheimer’s disease to volume and gene-expression changes in hypothalamic subregions for metabolism, stress response, and circadian rhythms, using 458 MRI subjects and 614,403 nuclei.
- Why it matters: The hypothalamus controls metabolism, stress, sleep, and neuroendocrine regulation, but how its distinct subregions and cell types shift across human ageing and AD is not well mapped.
- What they did: They built a human hypothalamus atlas combining high-resolution MRI from 458 individuals with single-nucleus RNA sequencing of 614,403 nuclei from young participants, AD patients, and age-matched non-dementia controls, then used machine learning to find cellular predictors.
- The result: In AD, inflammatory response and circadian regulators emerged as key predictors, with microglia shifting to a pro-inflammatory state and inhibitory neurons in sleep- and circadian-related subregions showing the strongest transcriptional disruptions, supporting HypoAD as a roadmap for targeted interventions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.